BridgeMD
New treatment option for Kidney Cancer
Official title Rein 3D PRINT MECHANICS
ClinicalTrials.gov ID: NCT06525831
What this study is testing
- What it's testing
- The goal of this innovative project is to evaluate the correspondence between several imaging modalities for characterizing the elasticity of healthy and pathological renal tissue which could help improve the realism of 3D prints used by urological surgeons and allow the identification of new, complementary imaging biomarkers. The main objective is to develop a predictive model of the biomechanical properties of normal and pathological kidney tissue, as assessed by the reference method (Magnetic Resonance (MR)-elastography).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients (≥ 18 years of age)
- Scheduled for surgical management with nephrectomy for kidney tumor in the urology department of Bordeaux University Hospital
- CT scan available or scheduled for surgery
- Consent expressed for integration of the UroCCR database
- Expressed consent for participation in the Rein 3D Print Mechanics study
You likely can't join if
- \- Pregnant or breast-feeding women
- Contraindication to MRI (Magnetic Resonance Imaging)
- Contraindication to injection of gadoline contrast agents
- Biopsy performed within 15 days prior to MRI, CT and ultrasound scans (risk of artifactual alteration, via iatrogenic hemorrhagic changes, of the...
- Presence of thoracolumbar arthrodesis material
- Obese patient (body mass index ≥ 30 kg/m²)
See the full eligibility criteria
- Adult patients (≥ 18 years of age)
- Scheduled for surgical management with nephrectomy for kidney tumor in the urology department of Bordeaux University Hospital
- CT scan available or scheduled for surgery
- Consent expressed for integration of the UroCCR database
- Expressed consent for participation in the Rein 3D Print Mechanics study
- Patients affiliated or benefiting from social security system
- \- Pregnant or breast-feeding women
- Contraindication to MRI (Magnetic Resonance Imaging)
- Contraindication to injection of gadoline contrast agents
- Biopsy performed within 15 days prior to MRI, CT and ultrasound scans (risk of artifactual alteration, via iatrogenic hemorrhagic changes, of the biomechanical properties of the renal tumor and parenchyma).
- Presence of thoracolumbar arthrodesis material
- Obese patient (body mass index ≥ 30 kg/m²)
- Cystic renal tumors with solid component (corresponding to either parietal thickening or tumor bud) \< 2 cm
- Necrotic renal tumors with solid component (corresponding to either parietal thickening or tumor bud) \< 2 cm
- Ascites
- Person under legal protection
- Difficulty understanding and expressing in French
The study team makes the final eligibility decision.
Where it's taking place
- Bordeaux, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bordeaux, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.